US Stock MarketDetailed Quotes

ALXO ALX Oncology

Watchlist
  • 6.150
  • -0.460-6.96%
Close Jul 19 16:00 ET
  • 6.320
  • +0.170+2.76%
Post 18:48 ET
320.42MMarket Cap-1657P/E (TTM)

About ALX Oncology Company

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.

Company Profile

SymbolALXO
Company NameALX Oncology
Listing DateJul 17, 2020
Issue Price19.00
Founded2015
CEOMr. Jason Lettmann
MarketNASDAQ
Employees72
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address323 Allerton Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-466-7125

Company Executives

  • Name
  • Position
  • Salary
  • Jason Lettmann
  • Chief Executive Officer and Director
  • 4.86M
  • Peter S. Garcia, M.B.A.
  • Chief Financial Officer
  • 1.30M
  • Shelly Pinto
  • Senior Vice President, Finance and Chief Accounting Officer
  • --
  • Dr. Sophia Randolph, M.D.,PhD
  • Director and Chief Medical Officer
  • 1.37M
  • Dr. Jaume Pons, PhD
  • President, Chief Scientific Officer and Director
  • 2.75M
  • Dr. Corey S. Goodman,PhD
  • Executive Chairman of the Board
  • 206.61K
  • Rekha Hemrajani
  • Independent Director
  • 181.02K
  • Scott Garland
  • Independent Director
  • 105.66K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg